ivWatch said today that it closed a $14.8 million financing round to support the company’s direct go-to-market initiatives and strategic partners activities.
Undisclosed angel investors, family funds and a major hospital system invested in the round, according to the company.
Get the full story at our sister site, Drug Delivery Business News.